Physician profile
Pretesh Parmar
NPI 1962806596
$2,254.29
in general payments reported to CMS, 2019-2025
14 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $218 · 2023: $411 · 2024: $914 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681 · Education: $137 · Travel and Lodging: $93.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.78 |
| Education | $137.01 |
| Travel and Lodging | $93.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $460.40 | 2024-2025 | Evenity, Krystexxa |
| Nevro Corp. | $319.29 | 2023-2024 | Senza |
| Horizon Therapeutics Plc | $240.03 | 2023 | Krystexxa |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Neurocrine Biosciences, INC. | $130.68 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2021 | |
| Heron Therapeutics, INC. | $124.98 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $121.91 | 2024 | Iovera |
| Kowa Pharmaceuticals America, INC. | $117.98 | 2022 | |
| Gilead Sciences, INC. | $117.61 | 2025 | Biktarvy |
| Alexion Pharmaceuticals, INC. | $117.46 | 2023 | |
| Teleflex LLC | $106.58 | 2024 | Urolift |
| Sanofi-Aventis U.S. LLC | $100.00 | 2022 | |
| Ethicon US, LLC | $35.36 | 2024 | Stratafix, Vistaseal, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pretesh Parmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.